The United States Agency for International Development (USAID) has awarded the Carolina Population Center at the University of North Carolina at Chapel Hill up to $181 million to continue its MEASURE Evaluation project.
HIV-infected patients have a higher prevalence of fractures than non HIV-infected patients, across both genders and critical fracture sites according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Pamela W. Barnes, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, and Alan Greenberg, professor and chair of the George Washington University Department of Epidemiology and Biostatistics, today announced the dual appointment of Laura Ann Guay, M.D., as vice president for research at the Elizabeth Glaser Pediatric AIDS Foundation and as research professor at The George Washington University School of Public Health and Health Services, Department of Epidemiology and Biostatistics.
A new collaborative study by researchers at Weill Cornell Medical College and the Clinton Foundation HIV/AIDS Initiative explores how to combine engineering science with medical care to guarantee the long-term success of these treatment programs.
AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.
Researchers at Wake Forest University Baptist Medical Center will soon begin researching how a lack of trust in formal medicine is contributing to disproportionately higher mortality rates in Latino HIV patients than in white HIV patients across the country.
Antiretroviral medications for HIV do not seem to increase the risk of cardiovascular events, suggest a pair of studies in the July issue of AIDS. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.
A Johns Hopkins expert in HIV and how the AIDS virus hides in the body says antiretroviral drugs have stopped HIV from replicating, the first of three key steps needed to rid people of the virus.
With the recent endorsement by the World Health Organization (WHO) and scientists worldwide of adult male circumcision as an important strategy for HIV prevention, there is increased urgency to develop safe and cost-effective circumcision services. This is especially the case in Africa where HIV/AIDS continues to spread at an epidemic rate.
With tens of thousands due to gather in Mexico City Aug. 3 for the 2008 International AIDS Conference, the journal AIDS has published a special supplement that provides concrete recommendations for addressing the complex social and economic issues that fuel HIV.
A common vaginal infection may make women more susceptible to contracting HIV, the virus that causes AIDS, University of North Carolina at Chapel Hill School of Public Health researchers have found.
Male injection drug users deported from the United States to Tijuana have four-fold higher odds of HIV infection compared to those living in Tijuana who were not deported there, according to a study to be presented at the International AIDS Conference on August 5, 2008 in Mexico City.
FREE ONLINE ACCESS to Psychosocial Aspects of HIV/AIDS published in the June issue of Psychosomatic Medicine. Visit www.psychosomaticmedicine.org to access this important information for free!
An Iowa State University design researcher is teaming up with the Mayo Clinic to transform her personal experiences with health care environments and information into more satisfying interactions for others. They will examine how design variables influence the decision-making process of diabetes patients using medical decision aids.
HIV patients taking a cocktail of drugs called combination antiretroviral therapy (cART) have seen a 13-year boost in life expectancy, according to a new study. Improved survival has led to a nearly 40 percent drop in AIDS deaths among 43,355 HIV-positive study participants in Europe and North America, bolstering the call for improved anti-HIV efforts worldwide, the study authors said.
Human Immunodeficiency Virus (HIV) researchers at The University of Texas Medical School at Houston believe they have uncovered the Achilles heel in the armor of the virus that continues to kill millions.
Does organ transplantation work as well in HIV-positive patients as in those without HIV infection? A new systematic review of six small studies indicates that the jury is still out. Since the late 1990s, patients with HIV are living longer because of effective medications and some physicians have "reconsidered their position" about organ transplantation for them.
The sound of a noisy Chicago restaurant during the breakfast rush "” the clang of plates and silverware and the clamor of many voices "” was the crucial test of new hearing aid technology in a study conducted by researchers at Washington University School of Medicine in St. Louis. The study showed that the hearing aids worked well in a noisy environment "” the most challenging test for a hearing aid.
Vaginal microbicides currently in clinical trials may be the only weapon that will protect women against infection from HIV. Yet, under likely circumstances, these microbicides may be of more benefit to men than women.
Robert S. Klein, MD a HIV/AIDS expert has joined the faculty at Mount Sinai School of Medicine as Professor of Medicine and member of the Epidemiology, Biostatistics and Disease Prevention Institute. Dr. Klein will be Director of Clinical Research of Infectious Disease in the Division of Infectious Disease at Mount Sinai. He will develop his own research program while mentoring junior clinical investigators within the Division of Infectious Disease.
Sandia National Laboratories researcher Georgianne Peek thinks a possible solution to high energy costs lies underground. And it's not coal or oil. It's compressed air energy storage (CAES).
Researchers are using minute, naturally occurring proteins called zinc fingers to engineer T cells to one day treat AIDS in humans.
Psychosocial influences such as stress, depression and trauma have been neglected in biomedical and treatment studies involving people infected with HIV, yet they are now known to have significant health impacts on such individuals and the spread of AIDS, according to a University of North Carolina at Chapel Hill scientist.
After recent efforts to develop a vaccine to protect against AIDS proved ineffective, the National Institutes of Health announced a change in research direction; and it's one that will involve the lab of James Crowe, M.D., professor of Pediatrics, Microbiology and Immunology at the Monroe Carell Jr. Children's Hospital at Vanderbilt.
Grandmothers raising their grandchildren orphaned by AIDS in Kenya and Tanzania are learning skills and developing economic self-reliance through a program created by Wake Forest University faculty member Mary Martin Niepold.
Adolescents attending college six months after they completed high school are significantly less likely to engage in risky sexual behavior than those who do not go college, according to the first study to directly compare the two groups.
The results of a randomized trial led by researchers at the Johns Hopkins Bloomberg School of Public Health and the University of Malawi College of Medicine found that extending the routine antiretroviral regimen can significantly reduce the risk of mother-to-child HIV transmission.
HIV-positive African American and Hispanic men who were sexually abused as children are particularly vulnerable to engaging in high-risk sex and experiencing depressive symptoms. Yet there are few intervention programs to help them. A new study finds that interventions that address their life experiences can contribute significantly toward preventing high-risk behavior and reducing depression rates.
As professionals dedicated to the provision of safe anesthesia care, the American Society of Anesthesiologists and the American Academy of Anesthesiologist Assistants take the opportunity to emphasize their commitment to optimal patient safety and to speak out regarding the importance of infection control procedures.
Einstein-Montefiore Center for AIDS Research receives $8.5 million award from National Institutes of Health as a specially designated "CFAR" site.
Dr. Andrew Owusu, assistant professor of health and human performance at Middle Tennessee State University, recently released the initial findings from a 2007 study that was the first of its kind to be conducted nationwide in Ghana, West Africa, on the health habits and health-risk behaviors of adolescents.
Researchers at the University of Pennsylvania School of Medicine have shown that monitoring treatment adherence to AIDS therapy is a simple blood-free way to monitor risk of disease progression.
A new study reveals in unprecedented detail the genetic identity of versions of HIV responsible for sexual transmission. In 80 percent of the study's newly infected patients, a single HIV variant caused transmission, according to researchers at the University of Alabama at Birmingham (UAB). The detail provides important clues in the ongoing search for an effective HIV/AIDS vaccine.
A new study shows infectious HIV hides out during drug treatments in a third type of reservoir cell. Called FDCs, these cells act as bank vaults storing material necessary to maintain the immune system's armies of antibodies. This advance will help the medical community figure out how to attack virus hidden by the reservoir cells.
Tulane University experts are available to speak on a variety of topics related to safety and summer.
The search for a viable HIV vaccine resonates strongly among those afflicted. In light of Merck's recent, high-profile HIV vaccine failure, and media articles calling for the abandonment of HIV vaccine research, an oft-overlooked approach may now take center stage, according to HIV expert Dr. Sylvain Fleury.
Major companies are creating a wide variety of programs to help employees deal with the global HIV/AIDS epidemic, according to a report released today by The Conference Board, the global business research and membership organization.
The Feinstein Institute for Medical Research announced today that it has signed a collaborative agreement with the renowned Karolinska Institutet in Sweden.
This study of patients' genes and clinical outcomes may signal the need for a change of thought in approaching HIV management.
An increase in the CD163+/CD16+ monocyte subset, which correlates with a patient's viral load, could serve as a biomarker for the progression of HIV disease.
Food insecurity linked with HIV/AIDS in Africa Queen's-led project to develop training, advocacy programs Determining how the HIV/AIDS epidemic increases food insecurity in African cities "“ and what can be done to reduce the chances of this happening "“is the focus of a new, international Queen's-led project.
Researchers at the University of Alberta have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS.
Researchers at The Scripps Research Institute have developed a new two-punch strategy against HIV and they have already successfully tested aspects of it in the laboratory.
Healthy middle-aged men who watch extensive online presentations about prostate cancer are more likely to understand the disease than those who simply visit health Web sites, a new study finds. The men are also slightly less inclined to undergo a routine but somewhat controversial prostate test, according to the study in the latest Archives of Internal Medicine.
About one in four women who have tested positive for the human immunodeficiency virus (HIV) expect pregnancy and motherhood to be a part of their future, recent research suggests.
An experimental anti-HIV gel is safe for women to use on a daily basis, according to research presented at an international microbicides meeting in New Delhi. The Phase II trial evaluated if tenofovir was safe to use every day for six months, or safe to use prior to each act of sex. Both approaches were found safe, paving the way for a larger study to see if the gel prevents HIV infection, the study authors said.
In an effort to strengthen and broaden its global health research and project implementation capabilities, RTI International has hired an internationally recognized team of researchers who together comprise the Women's Global Health Imperative formerly at the University of California at San Francisco.
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.
Patients with insomnia who are diagnosed with accompanying mental health ailments often are not prescribed medication that will help them sleep "“ which could then make related anxiety or depression worse, new research suggests.
Worldwide scholars and poets, authors and reviewers of African literature will convene at Western Illinois University in Macomb April 22 -27 for the 34th Annual African Literature Association Conference, "African and African Diaspora Women Writers, Global Challenges and Cultural Identity."
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right